Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15657157 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Kidney Failure, Chronic;   Hyperlipidemia
Intervention: Drug: Extended release niacin

Indicates status has not been verified in more than two years